Comparisons

Pumpkin Seed or Saw Palmetto?

Pumpkin seed (Cucurbita pepo) is eaten as a food, while saw palmetto (Serenoa repens) is sold as an extract; both are used for urinary symptoms of benign prostate enlargement. The table is built from the sourced cards of both herbs.

Pumpkin Seed or Saw Palmetto?
AspectPumpkin SeedCucurbita pepoSaw PalmettoSerenoa repens
Strongest evidenceB Limited clinical evidence— No rated benefit
NeedsMen’s Health, Liver, Kidney & Urinary—
FormSeedClay, Soap & Other
How to useAdults eat 2.5–7.5 g of seeds (whole or cracked).A clinician should first assess the cause of urinary symptoms. If a finished product is chosen, follow its own instructions and the clinician’s assessment.
PregnancyCautionAvoid
BreastfeedingCautionAvoid
Recommended minimum ageFrom age 18From age 18
Drug interactionsNo recorded interactionsInteractions reported
Duration limitLong-term use is possibleNot stated

Which one, when?

Pumpkin Seed

In a one-year trial of 1,431 men, 5 g of pumpkin seed twice a day reduced symptom scores more than placebo; confirmatory trials are needed. Also traditionally used for overactive bladder and can be eaten long term.

Full card →

Saw Palmetto

A review of 27 studies found little or no benefit on its own for prostate symptoms; the EMA assesses only one specific hexane extract under well-established use. Raised INR has been reported with warfarin.

Full card →

Good to know

  • The cause of urinary symptoms must first be checked by a doctor; neither is recommended under 18.
  • See a doctor at once for fever, cramps, blood in the urine, painful urination or urinary retention.

Sources

  1. Community herbal monograph on Cucurbita pepo L., semenEMA HMPC · 2012 · MonographSource accessed:
  2. European Union herbal monograph on Serenoa repens (W. Bartram) Small, fructusEMA HMPC · 2015 · MonographSource accessed:
  3. Saw Palmetto: Usefulness and SafetyNIH NCCIH · 2025 · Official agency informationSource accessed:
  4. Effects of pumpkin seed in men with lower urinary tract symptoms due to benign prostatic hyperplasia in the one-year, randomized, placebo-controlled GRANU studyUrologia Internationalis · 2015 · Randomized controlled trialSource accessed: